Previous Page  3 / 5 Next Page
Information
Show Menu
Previous Page 3 / 5 Next Page
Page Background

Page 21

Notes:

3

rd

International Conference on

Health Care and

Health Management

Joint Event

&

November 04-05, 2019 | Prague, Czech Republic

6

th

International Conference on

Neuroscience and

Neurological Disorders

Journal of Public Health Policy and Planning | Volume 3

Microelectrode recording and deep brain stimulation

Amal Mokeem

King Faisal Specialist Hospital & Research center, KSA

Introduction:

Microelectrode recording (MER) Defined as

Neurophysiological Technique that detect and amplifies the

activity of Individual Single Neural Units.

Mechanism of Deep Brain Stimulation (DBS):

• HFS suppresses the activity of STN, STN neurons

discharge spontaneously at a frequency of ~ 20 Hz.

• PD they became hyperactive with an average firing ~

40Hz.

• DBS HFS at >100Hz, STN will increase firing during the

initial stimulation period after which they will fail to

respond secondary to inactivation of Na

+

channels,

result in synaptic inhibition.

• This stimulation induced activation of inhibitory

presynaptic terminals result reduction of pathologic

activity and its transmission, and subsequent

improvement in information processing high likely

responsible for amelioration of motor symptoms during

DBS

The Food and Drug Administration (FDA) approved DBS as a

treatment for:

• Essential tremor in 1999

• Parkinson's disease in 2002

• Dystonia in 2003

Methods:

Ptients slection criteria is important. A number of

stimulation techniques may be performed during movement

disorder surgery.Used either:

• To asses’ side effect (proximity to structures wish to

avoid)

• To assess the potential clinical effect of chronic

stimulation.

Conclusion:

Deep Brain Stimulation (DBS) is safe procedure.

It is safety Greatly depend on:

• The quality of the instruments.

• The method of stereotactic planning.

• The experience of the surgical and neurophysiology

team.

Complication of Deep Brain Stimulation (DBS) could be

Numbness, tingling, Symptomatic subdural hemorrhages,

Infection, Hardware issues.

Speaker Biography

Amal Mokeem is a Consultant Clinical Neurophysiologist at King Faisal

Specialist Hospital and Research Centre, Saudi Arabia. She has been in the

Arab Board – Dec 2003 and Saudi Board – Feb 2004. She has done Pediatric

Neurology Fellowship at King Faisal Specialist Hospital & Research Centre,

Riyadh, Saudi Arabia during 2004-2006, at British Columbia’s Children’s

Hospital, Canada during 2006-2007, Clinical Neurophysiology EEG

Fellowship at British Columbia’s Children’s Hospital, Canada during 2007-

2008, Clinical Neurophysiology Intraoperative NeurophysiologyMonitoring

(IOM) Fellowship at Vancouver General Hospital, Canada (2008-2009) and

Neurophysiology and Deep Brain Stimulation Fellowship at Lahey Clinic/

Tufts University, USA (2009-2010). She is having 2 Publications and gave

more than 10 International Presentations.

e:

aamokeem@gmail.com